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ABOUT THE FETAL RISKS FROM DIAGNOSTIC USE OF RADIATION DURING 
PREGNANCY: A SYSTEMATIC REVIEW AND PROPOSAL OF A CLINICAL PROTOCOL 
 
ABSTRACT 
Aim: Analyze existing literature about the fetal risks of radiation exposure, producing a clinical 
protocol to guide radiation exposure in a clinical setting. 
Methods: An initial query was made on PubMed: “Diagnostic radiography in pregnancy AND 
radiation”, with the limits “published from January 1st 1993 to December 31st 2013, in English or 
Portuguese”. The articles that presented our aim were analyzed according to their MESH terms and 
created the final query:  “((radiation) AND pregnancy) AND diagnostic imaging”. Research on April 15th 
of 2014, with the same limits, on PubMed gathered 688 articles; on SCOPUS 245 additional articles. 
After reading the title and abstract 298 articles remained. 179 allowed access to full text and were 
analyzed according to inclusion and exclusion criteria. A total of 103 articles were used and an additional 
one regarding In utero radiation exposure from atomic bombs. The PRISMA statement was followed. 
Results: Deterministic effects like pregnancy loss, congenital malformations, growth retardation 
and neurobehavioral abnormalities have threshold doses greater 100-200 mGy, being the risk considered 
negligible at 50 mGy. No diagnostic exam exceeds this limit. The most crucial time to avoid radiation 
exposure is from the 8th to the 15th week of gestation. The risk of carcinogenesis is slightly higher than the 
general population, although very similar. Intravenous contrast is discouraged, except in highly-selected 
patients. 
Conclusion: Measures to diminish radiation are essential and affect the fetal outcome. 
Nonionizing procedures should be considered whenever possible and every radiology center should have 
its own data on fetal radiation exposure.  
 
KEYWORDS: Diagnostic Imaging; Fetal Risks; Pregnancy; Radiation. 
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INTRODUCTION 
 
Everyday medical practitioners face the dilemma of exposing pregnant or presumably pregnant 
patients to radiation from complementary diagnostic exams [1-3]. In fact, irradiation of the fetus is a very 
common phenomenon [1], but one should be aware of the implicated risks [4]. 
There are many circumstances for fetal exposure to radiation. The most common one, especially 
during the first trimester, is accidental as the patient was not aware of the pregnancy [5-11]. To this we 
add the need for medical diagnosis of the mother (at any given time during gestation) or the fetus (to 
confirm an abnormality or provide further information, usually after ultrasound during the 2nd and 3rd 
trimesters). More frequently irradiation during pregnancy derives from diagnostic need for both mother 
and fetus, if no alternative to ionizing radiation is available [1]. Finally, special consideration should be 
granted to pregnant radiology staff [6,7,11].  
Much of the information regarding radiation exposure of the fetus comes from “opportunistic” 
accidents in the world’s history. Survivors of the atomic bombs of Hiroshima and Nagasaki have shown 
risks of fetal exposure to radiation, the most common one being microcephaly at 100-200 mSv [5,12-14]. 
Mental retardation was also observed among survivors (20-30 points per 100 rad; 25-31 points per Gy 
above 0.1 Gy) [12,13,15,16], as well as growth retardation (permanent above 250 mSv, 25 rad or 0.25 
Gy) [5,13], teratogenesis (above 1Gy)   and cancer (increased rate of leukemia) [13]. Studies on cancer 
after intrauterine exposure to the atomic bomb are inconsistent [17]. The Chernobyl reactor accident was 
also associated with increased rate of cancer [13]. Studies on children exposed to radiation before 15 
weeks of gestational age showed a higher susceptibility to these effects [12].  
Ionizing radiation is frequently used with the purpose of achieving a medical diagnosis since the 
discovery of X rays [18] and is still a helpful tool. In recent years there has been a great concern in 
developing new techniques and methods to decrease the risk of radiation for pregnant women and, just as 
important, to their fetus [4,19]. 
Both doctors and patients often have questions about the risks of radiation. Therefore, creating a 
guideline is not only a useful tool for every medical practitioner but also a necessity [1]. The main 
objectives of this systematic review are to analyze the existing literature about the risks of radiation 
exposure and safety of contrast agents. Additionally, a clinical protocol is proposed to guide radiation 
exposure in a clinical setting. 
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METHODS 
 
The present article is a systematic review that aims to analyze the existing literature about the 
fetal risks from radiation exposure during pregnancy. An initial query was made on PubMed: “Diagnostic 
radiography in pregnancy AND radiation”, with the limits “published from January 1st 1993 to December 
31st 2013, in English or Portuguese”. This research yielded a total of 381 articles. Those who presented 
the same objective as intended in this systematic review where analyzed according to their MESH terms. 
Gathering the most frequent MESH terms the final query was created:  “((radiation) AND pregnancy) 
AND diagnostic imaging”. On April 15th 2014, the total of articles retrieved from this research on 
PubMed was 1462. After applying the same restrictions to publication date and language, 688 articles 
remained, 261 of them reviews. The same query and research limits were applied on SCOPUS, gathering 
an additional 245 articles (Fig. 1 – Flowchart of the methods). After reading the title and abstract, when 
available, 635 were excluded.  
The main inclusion criteria considered: 
 Radiation doses absorbed by the fetus; 
 Risks of radiation from diagnostic exams to the fetus; 
 Protection measures for diagnostic radiology exams in pregnant women. 
 
The following excluding criteria were also used: 
o Studies on radiotherapy; 
o Studies on occupational hazards of radiation; 
o Risks of ultrasound; 
o Discussion of ethical problems regarding radiation usage; 
o Molecular studies of radiation rather than clinical ones; 
o Articles with an iconographic purpose; 
o Studies on animals other than Humans; 
o Studies with the objective of comparing diagnostic exams for specific pathologies regardless of the 
risks for the fetus (for example: comparison of sensitivity and specificity of two different 
diagnostic exams). 
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From the 298 final articles, 179 allowed access to full text and were analyzed according to 
different variables: dosages of radiation absorbed by the fetus according to the irradiated area of the 
pregnant woman, effects and safety limits of radiation. A total of 103 articles were used and an additional 
on regarding in utero exposure from atomic bombs (Fig. 1 – Flowchart of the methods). The PRISMA 
statement was followed for the construction of this systematic review. As a result of our research from the 
literature, a protocol for medical use was designed. 
 
DOSAGE OF RADIATION TO THE FETUS 
 
Background radiation is considered to vary across the globe [4] between 1.3-5.8 mSv/year [20], 
being that the average annual effective dose from it is about 3.6 mSv (0.36 rem) for an adult [3,15,21,22] 
and 0.5-1 mSv or 1.1-2.5 mGy [23,24] for a fetus during the entire period of gestation [3,25-28]. The 
fetus is more radiosensitive than the mother [28,29]. 
If a pregnant woman is in need of medical care and, to achieve diagnosis, requires the use of a 
diagnostic procedure that will expose her unborn child to radiation, we need to take into account not only 
the type of energy but also the quantity of photons, size of the patient and vulnerability of irradiated 
tissues. However, quantifying the dosage delivered to the fetus is not an easy task [21,30]. 
In radiographic and fluoroscopic examinations, if the uterus is outside the field of view, the fetus 
is only exposed to scattered radiation in minimal doses [31,32]. Therefore, the fetal exposure increases if 
the uterus is within the field of view (Table 1). It appears that posteroanterior chest x-rays exposes the 
fetus to less radiation than the anteroposterior projection [31]. The dosage applied to the fetus in 
radiography depends on the patient thickness, the direction of projection, the depth of the fetus from the 
skin surface and x-ray technique factors [25,33] (Table 1).  
Maximum exposure of the fetus to radiation comes from abdominal computed tomography (CT) 
[18,25]. However, the dosage is minimal and the patient can benefit significantly from the exam [25] 
(Table 1). If the abdomen is not in the field of view, the fetus is only exposed to scatter radiation [24]. 
The fetal radiation dose from a CT depends on kilovolt peak, milliamperes, slice thickness [34], 
gestational age, the depth of the fetus and proximity of the uterus to the field of interest [25,35] (Table 1). 
The mean effective dose of radiation for each procedure to the mother, the fetal exposure and the 
fetal equivalent dose (Table 2) and the number of exams needed to reach the accepted cumulative dose of 
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fetal exposure (Table 3) are presented. The measurements vary extensively, requiring each radiology 
department to have access to its own data. 
 
RISKS TO THE FETUS FROM RADIATION OF DIAGNOSTIC EXAMS 
 
When using radiation we have to consider two kinds of effects: deterministic and stochastic. 
Deterministic effects are those whose severity increases with the dose of radiation, having a threshold 
dose below which its effect is clinically irrelevant. For them to have an effect on the fetus, the threshold 
dose must be reached. After this limit, the severity of the effect increases with the dose 
[3,5,13,16,32,34,36-45]. Stochastic effects are those whose probability of occurring increases with the 
dose, not caring for a threshold dose because the result is the same (acting on one single cell or a group of 
them). The severity of the effect is dose-independent [3,5,13,16,21,32,34,37-45]. 
The effects of radiation on the fetus depend on the stage of the pregnancy, radiation dose 
[5,8,11,13,15,23,32,46-48] and fetal cellular repair mechanisms [25]; demographic factors (patient age 
and weight), medical history factors (coexisting diseases, genetic factors, medication use and radiation 
history) and procedure factors influence as well [3,16,23,28,40,42,49]. We can divide the fetal effects of 
radiation in: 
1. Pregnancy loss; 
2. Congenital malformations (teratogenesis) [21,34]; 
3. Neurobehavioral abnormalities [13]; 
4. Fetal growth retardation [9,36,50]; 
5. Carcinogenesis [9,21,34,36,50,51]. 
 
1. Pregnancy Loss 
At the beginning of every pregnancy the risk of spontaneous miscarriage is about 15% 
[3,16,24,32,36]. After conception and during preimplantation and preorganogenesis, the embryo cells are 
omnipotential. This means that it is unlikely for malformations to occur by the effects of ionizing 
radiation during these stages. Other cells can replace adjacent cells that have been deleteriously affected. 
This period is called “the all-or-none period” [11,13,14,36,49]. 
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If the exposure to radiation exceeds 100 mGy or 100 mSv during the first 2 weeks after 
conception, the “all-or-none” phenomena can result in spontaneous abortion instead of a completely 
unaffected embryo [3,5,11,14,16,20,28,34,38,44,45,48,49]. From the fourth to eight week of gestation, 
the threshold goes up to 150mGy [42], 200 mGy [45] or 250 mGy and 500 mGy [36,52]. After 26 weeks 
the risk of neonatal or fetal death rises with doses above 1Gy, with a threshold of 100 mGy [34,53,54]. 
Exposure to less than 5 rad (50 mGy) has not been associated with increased fetal anomalies or 
pregnancy loss [25,45,46,55]. The exposure to radiation on its own is not an indication for terminating the 
pregnancy [5,9,13,25,46] and should only be considered if the exposure dose is higher than 100 mGy – 
“Danish rule” [7,20,24,31,39,49,56]. Some propose a limit dose of 150 mGy [8].  
 
2. Congenital Malformations 
In every pregnancy the background risk for birth defects is about 3% [3,13,16,24,32,36]. The 
most sensitive period for malformations is from the 2nd to 8th week of gestation, during organogenesis 
[13,21,34,50] and during the early fetal period (up to 15th week) [11,14], with a threshold of 100 mGy 
[15,18,23,28,31,38,48,56-58]. A threshold of 150 mGy [3,8,10,25,41,59,60], 200 mGy [3,11,15,20,36] or 
250 mGy [25,45] has been suggested. After 16 weeks, the threshold is about 500 mGy to 700 mGy 
[11,45,52]. During the last trimester major organ malformations and functional anomalies are unlikely 
[13,14]. There has been no evidence of congenital malformations at doses below 50 mGy or 5 rad being 
this value the accepted cumulative dose of ionizing radiation for the entire gestational period 
[11,16,20,25,31,55,56,61]. No diagnostic exam exceeds this limit [9,13]. The risk of malformations is 
significantly increased above 150 mGy (15 rad) [13,16,26,46]. When the dose of exposure exceeds 100 
mGy the probability of congenital birth defects increases 10% [62].  
In the light of current knowledge, diagnostic x-rays, CTs or nuclear medicine procedures cannot 
be considered a risk for malformations [11,20,25,26,53]. 
 
3. Neurobehavioral Abnormalities 
The background risk for neurological development problems is about 1% [3,24,32] up to 6% [5] 
The most sensitive stage for mental retardation and microcephaly is from the 8th week to 15th week of 
the gestational period [3,9,11,13,15,16,36,47,58,63]. Exposure up to 20 weeks of development increases 
the risk of microcephaly and mental retardation [13,21]. However, from the 16th to the 25th week the 
7 
 
central nervous system is less radiosensitive [3,13-15,63]. After the 25th week it becomes radioresistent 
[13]. 
Mental retardation has a threshold of 100 mGy to 250 mGy [3,13,15,16,20,25,28,38,44,45,48,55] 
or 120 mSv [18] and is not directly linked to microcephaly [13,48].Severe cases occur with higher doses: 
350-500 mGy [16,20,36,45] or even 1 Gy [20,34], 120-230 mGy between 8th and 15th weeks, 210 mGy 
between 16th and 25th weeks [13]. The IQ loss is about 25 to 31 points per 1 Gy beyond 100 mGy of 
radiation [11,15,41,45,63] or 21-29 IQ points per Gy, 30 points for every Sv [13]. Eight weeks after 
conception, intellectual damage has not been demonstrated [58]. But others find that at 8 to 15 weeks the 
incidence of severe mental retardation establishes a linear connection without a threshold dose, with an 
increased risk of 40% per gray of radiation [9,14,15,50,63] or 40% per 100 mSv to 200 mSv (200 mGy) 
[5]. After this period,  the incidence is lower and doses from 20 mGy to 250 mGy may show cognitive 
loss [50], although it is more common at high doses (>=200 mGy) [64]. In the 16 to 25 week stage the 
average IQ loss is approximately 13-21 points per Gy (per 100 rads) at doses above 700 mGy [13,15,63]. 
Microcephaly occurs at a threshold of 100 mGy [28], 200 mGy [48] or 350 mGy to 500 mGy [31,36].  
Based on the evidence seen so far, no diagnostic exam (x-ray, CT or nuclear medicine 
procedures) can cause neurodevelopment effects [20]. 
 
4. Fetal Growth Retardation 
Growth retardation due to radiation exposure has a risk of 4% in all pregnancies [3,16,24,32]. It 
occurs mainly during the first trimester, after 14 days of conception [34]. Exposure to radiation up to 20 
weeks of development increases the risk of growth retardation [21]. It shows a dose threshold of 100 mGy 
to 250 mGy [16,25,44,55], in some studies up to 500 mGy [20,36,45,52], 1 Gy [15] or 50-100 mSv 
[1,15]. Growth retardation usually is not permanent and the fetus will recover [5]. 
Dental radiography during pregnancy is associated with low birth weight [13,16,65]. 
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5. Carcinogenesis 
Cancer and hereditary effects after radiation exposure occur without a threshold dose 
[9,17,24,25,31,49,52,60,66] and appear at the same age as spontaneous ones [50]. The risk of this 
occurrence is constant throughout the whole pregnancy [15,28,34,48] except for the first two/three weeks 
of pregnancy when the risk is low [51,58]. After radiation exposure to the fetus there is an increase in risk 
for all cancers [14,26,30,32,35,67] (including solid tumors [11,16]) and leukemia, especially acute 
myeloid leukemia. However, this is not statistically significant [67]. 
After pelvic procedures like barium enema or CT, the carcinogenic risk is similar to the natural 
incidence of fatal carcinogenic risk before age 15 [14]. If the absorbed dose is 5 rad, the risk of childhood 
cancer is 0,3% (0.2-0.8%) - the same value as the natural risk for fatal childhood cancer [14-16,47,58]. 
The risk can be of 0.06% per 10 mSv or 10 mGy [1,28,39] or 0.06% per 1 rad [47], 5% per Sv (100 rem) 
[5] (Table 3). Others say that 100 mGy of radiation increases the risk for childhood cancer by 0.1% [52]; 
a dose of 10 mSv during the last trimester increases the risk of leukemia by 40%. 10 mSv at any stage of 
the pregnancy increases the risk of leukemia by a multiple of 1.5. Doses above 10 mSv increases the risk 
coefficient 6% per Sv [5]. The most consensual attitude is to consider a risk slightly higher than the 
general population, but still very similar [45].  
Most of the articles included in this review mention leukemia as the most common carcinogenic 
phenomenon associated with in utero radiation [9,32,37,42]. However, leukemia associated with high 
exposure to radiation is not more severe than a spontaneously occurring leukemia [36]. The background 
risk is about 3.6 per 10000; after exposure increases to 5 per 10000 [9]. In utero exposure to 0.01 Gy 
increases the risk of cancer in the first and second decades of life from 0.03% to 0.04% [37]. 
Some studies report that radiation exposure at all gestational ages increase the risk of childhood 
leukemia [21,68] but others find that there is little evidence of any increased risk of childhood acute 
lymphoblastic leukemia associated with maternal x-rays during the pregnancy [69]. In some cases it has 
been recorded an excess of maternal x-ray exposure among children with acute lymphoblastic leukemia 
but the statistical analyses and experimental data were reassuring and do not support this connection [68].  
Although perfusion scanning exams do not pose a risk for deterministic effects they can be 
linked to cancer or genetic effects, regardless of the dose [62]. Carcinogenesis associated with diagnostic 
radiation is a dose independent event but the risk seems relatively low with doses less than 10 rad (100 
mGy) [3,14,16,37,41,42,70] or 10 mSv [22,70]. A cutoff of 50 mGy has also been proposed [41]. 
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Complementary use of contrasts 
Intravenous contrast is discouraged during gestation, except in highly-selected patients where 
there is no other alternative to obtain important diagnostic information [71]. These contrast agents are 
used in CT and MRI to detect, characterize and stage diseases [72]. There are two main contrast agents: 
iodine or gadolinium-based.  
Radioiodine crosses the placenta and starts to accumulate in the fetal thyroid since the 12th week 
of gestation, not exceeding the 100 mGy limit [20,23,41,46,66,73]. We have to consider the possible risk 
of hypothyroidism and thyroid cancer induction to the fetus, so radioiodine is contraindicated during 
pregnancy [3,20,23,24,26,34,49,74,75]. Internal uptake of iodine occurs mostly during the 16th to 25th 
week stage [15]. However, there aren’t sufficient human studies on fetal thyroid depression due to iodine 
[46,53] and it has not been observed with the administration during pregnancy [28,39]. It is considered 
generally safe during pregnancy and therefore iodinated contrast could be used during pregnancy after 
assessing the risk-benefit ratio [7,8,24,39,49,74,76,77]. If the mother received iodinated contrast material 
during her pregnancy, the thyroid function of the newborn should be evaluated in his first week of life 
[23,26,37,41,49,73,75]. Evidence of mutagenic or teratogenic risk does not exist, but there is a lack of 
human studies [3,23,24,37,48,66,75]. 
Gadolinium-based contrast cross the placenta, enter the fetal circulation and are excreted into the 
amniotic fluid, where they remain for some time [3,39,41,66,78,79]. It appears there are no teratogenic or 
mutagenic effects in humans when using these agents [3,39,41,46,66,72,75,76] but gadolinium’s safety 
has not been established [3,23,34,37,74,79]. Apparently nephrogenic systemic fibrosis and dissociation of 
toxic-free gadolinium are some of the effects in discussion [46]. At higher doses than the ones used in 
human studies gadolinium has been associated with growth retardation and congenital anomalies [26]. 
Gadolinium should be contraindicated during pregnancy, only used when the benefits outweigh the risks, 
with extreme caution [8,27,28,39,47,49,74,76,80]. 
Barium sulphate is used during fluoroscopic exams and appears to be safe for the fetus [81]. 
 
Computed Tomography 
Computed Tomography (CT) examinations on pregnant women are usually in areas away from 
the uterus, so the fetus is not directly exposed to radiation. The risk in these cases is scatter radiation that 
only hits low levels of radiation, thus carrying a small risk for the fetus [29]. 
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CT of maternal head and chest have negligible fetal exposure. Maternal pelvic CT may increase 
the risk of cancer [53]. Computed tomography pulmonary angiogram exposes the fetus to similar or lower 
doses of radiation as V/Q scans [82]. Helical CT has an average fetal exposure dose smaller than 
ventilation-perfusion lung scanning [83]. 
 
Magnetic Resonance Imaging 
Non ionizing procedures should be considered whenever possible [26,42,43,84-86]. In fact, 
Magnetic Resonance Imaging (MRI) should be the second line examination, after ultrasound, because it is 
an expensive, complex and less available exam [6,46,76,80,87-89]. 
MRI can be performed at any stage of the gestational period, but safety during the first trimester 
is not yet established [16,46,49,78,79]. The major concerns are heating effects of radiofrequency pulses 
and effects of acoustic noise on the fetus [6,26,41,47,49,74,89-91]. Thermal heating can cause biologic 
damage, related to cell migration, proliferation and differentiation, up to and including miscarriage 
[74,87,91]. The central nervous system is especially sensitive to heat rising. A 2°C rise over 24h can 
result in abnormalities like neural tube and cranio-facial defects [6,90,91]. Some say that MRI should be 
avoided in the first trimester to avoid excessive heating and high fetal exposure; however, after 24 weeks 
(when the fetal hearing is developing) is not easy to give additional protection from acoustic noise to the 
fetus [3,41,92]. Acoustic damage appears to be a more theoretical risk and not a significant practical issue 
[8,49]. 
MRI shows no harmful effects on the fetus under 1.5 Tesla [7,18,26,28,39,41,49,93], considered 
generally safe for use in pregnant women [46,76,84]. In some radiology centers higher field strengths are 
used with no apparent risk to the fetus. The use of 3 Tesla equipments is gradually being introduced in 
clinical practice. Field strengths above 2.5 Tesla should be avoided [3,26,41,92]. Safety of the fetus is 
overestimated because the effect of heat dissipation by convection in the amniotic fluid is overlooked. 
There should be more studies on this matter [93]. 
Until today no evidence of conclusive harmful effects to the fetus from MRI exists 
[3,8,41,47,78-80,87,89,91]. 
 
The risk is considered to be negligible at 50 mGy or less [3,5,8,13,15,16,23,28,38,43,52] and 
diagnostic exams have lower doses [3,23,24,37,45,48,52,75]. Deterministic effects have thresholds 
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greater than 100-200 mGy (below are considered safe) [14,32,45,56,64] and the most crucial time to 
avoid radiation exposure is from the 8th to the 15th week of gestation [86]. Measuring the dosage of 
exposure is important to determine the risk to the fetus [28,61]. 
 
MEASURES TO DIMINISH THE RISKS OF RADIATION 
 
Accurate imaging helps to achieve a definitive diagnosis, deciding proper treatment, avoid 
complications and unnecessary interventions [76,80]. Withholding proper diagnostic imaging care can 
result in significant harm for the mother and therefore to the fetus, considered an irresponsible medical 
action [64]. Protection in radiology follows some basic principles: there should be no risk without benefit, 
prescribed limits should not be exceeded and, at all times, the “ALARA” concept (as low as reasonably 
achievable) should be kept [21,23,26,38,40-42,46,52,77]. Therefore, measures to reduce the dosage to the 
fetus should be implemented. 
 
Screening for pregnancy 
The first step to take is screening for pregnancy [2,38,40,45,78,79]. The “10 day rule” states that, 
in women of childbearing potential, non urgent radiography examinations that involve pelvic irradiation 
should be restricted to the first 10 days of the menstrual cycle [51,54,57,58]. Hence avoiding irradiating 
the fetus before the mother knows that she is pregnant [51] and the risk of pregnancy loss [57].  
Recently, the accepted interpretation is that if the patient’s menstruation started less than 10 
days, the chance of pregnancy is very low and no cause of concern [54]. Most radiology departments no 
longer follows this principle [57]. 
In all situations, informed consent should be acquired, if the patient is stable [38,40,79]. 
 
General measures 
Ionizing radiation should be avoided especially during the first trimester but, whenever possible, 
through the whole pregnancy ultrasound and MRI should be preferred [26,41,76,85,86]. Special care is 
advised between 10 and 17 weeks because of the risk for central nervous system teratogenesis. In this 
period, non urgent exams should be postponed [9,47]. 
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Additionally, all radiologic equipment should be well-maintained and periodically inspected for 
radiation safety [2]. It is important to monitor the radiation dose of every exam [5,40]. 
For all diagnostic exams is important to minimize exposure time [2,35,44,46,58,61,77,94-96]. In 
a general way, protraction and fractionation of exposures of ionizing radiation to the embryo decrease the 
magnitude of the deleterious effects of deterministic effects [36]. Radiography, fluoroscopy and 
computed tomography share the following measures:  
 Lead shielding whenever possible [5,8,14,16,23,24,28,38,40,41,43,61,76,77]; 
 Collimators [3,5,23,28,41,46,48,61,77,97,98]; 
 Minimize the number of acquisitions [2,23,41,42,48,55,61]; 
 Scan the minimum body area needed to provide sufficient guidance [3,24,32,41,42,61,99,100]. 
Specific technicalities adopted in radiographic, fluoroscopic and CT examinations are detailed in 
the clinical protocol section. 
 
CLINICAL PROTOCOL 
 
Every female patient in reproductive age should be screened for pregnancy before undergoing 
diagnostic radiation exams. If the pregnancy is a possibility or confirmed the risks of radiation to the 
mother and fetus need to balance with the benefit of the exams.  
Deterministic effects like pregnancy loss, congenital malformations, growth retardation and 
neurobehavioral abnormalities have threshold doses greater 100-200 mGy [14,32,45,56,64] (Table 1 
Protocol), being that the is considered to be negligible at 50 mGy or less [3,5,8,13,15,16,23,28,38,43,52]. 
No diagnostic exam exceeds these values [3,23,24,37,45,48,52,75](Fig. 2 – Comparison of the minimal 
threshold doses for the deterministic effects of radiation with the accepted cumulative radiation during 
pregnancy). Moreover, the most crucial time to avoid radiation exposure is from the 8th to the 15th week 
of gestation [86]. The risk of carcinogenesis is slightly higher than the general population, but still very 
similar and should be considered during the entire gestational period [45].  
Intravenous contrast is discouraged during gestation, except in highly-selected patients where 
there is no other alternative to obtain important diagnostic information [71]. 
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For radiography and fluoroscopy: 
 Highest peak kilovoltage possible that results in acceptable image contrast [33]; 
 Lead shielding whenever the abdomen or pelvis is not being imaged to protect the uterus from 
external scattered radiation [5,14,16,28,38,40,43,61,76,77]. If a specifically designed shield is 
not available, lead aprons should be reserved specifically for this task [101]; 
 Minimize fluoroscopy time [2,44,58,61,77,94,95] and the number of images acquired during 
digital subtraction angiography and cinematic acquisitions [2,55,61]; 
 Magnification only if necessary [41,61]; 
 Perform pulsed fluoroscopy at the lowest pulse rate that provides sufficient image quality 
[41,61,77]; 
 Maximize the distance between the x-ray source and the receptor and the distance between the 
patient and the receptor [40,61,77]; 
 Collimators [5,28,41,48,61,77];  
 Decrease Filtration[5] with copper [77]; 
 Avoid taking radiographs during fluoroscopy [77]; 
 Increase tube voltage [77]; 
 Posterior-anterior projection should be preferred to anterior-posterior projection [18,28]. 
In a general way, protraction and fractionation of exposures of ionizing radiation to the embryo decrease 
the magnitude of the deleterious effects of deterministic effects [36]. 
 
For Computed Tomography: 
 Lead shielding if it does not affect the image result, best with circumferential shielding [5,8,23-
25,41,43,98,99,102]; 
 Reduce kilovoltage peak [3,4,23,24,35,41,42,52,96,98,100], milliampere-second setting 
[4,41,42,96,100], the length of the scan [35,46,96] and the number of acquisitions 
[23,41,42,48,61]; 
 Center the patient in the CT Gantry [99]; 
 Use a low tube current-time product for all acquisitions after the preliminary scan 
[3,23,24,42,43,48,52,61,73,98]; 
 Scan the minimum body area needed to provide sufficient guidance [3,24,32,41,42,61,99,100]; 
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 Increase the pitch [3,23,41,42,61,97,98]; 
 Limit Z axis [23,35,98]; 
 Internal barium shielding with use of oral 30% barium sulfate solution [23,41,43,99]; 
 Customize protocols to patient size and clinical indication [98]. 
Since CT scans are associated with higher radiation exposure dosage than other medical exams, 
its use should be restrained [21,76]. Here the alternatives (ultrasound and MRI) have to be considered and 
offered to the patient if the benefit is higher than the risk [9,21,38]. 
Every radiology center should have its own data on fetal radiation exposure in order to determine 
the risks [28,61]. 
 
CONCLUSION 
 
With the increase of technology and availability of diagnostic exams, more and more pregnant 
women are irradiated unaware of their current state. The risks of fetal exposure to radiation are still very 
misunderstood by the general population and, to some degree, even by medical professionals. When using 
radiation to achieve a diagnosis, one has to balance the welfare of the mother and of her unborn child, 
weighing the risks and benefits. [21,64] 
Deterministic effects like pregnancy loss, congenital malformations, growth retardation and 
neurobehavioral abnormalities have threshold doses greater 100-200 mGy [14,32,45,56,64], being that the 
risk is considered to be negligible at 50 mGy or less [3,5,8,13,15,16,23,28,38,43,52]. No diagnostic exam 
exceeds these values [3,23,24,37,45,48,52,75]. Moreover, the most crucial time to avoid radiation 
exposure is from the from the 8th to the 15th week of gestation [86]. The risk of carcinogenesis is slightly 
higher than the general population, but still very similar [45] and should be considered during the entire 
gestational period [45]. Intravenous contrast is discouraged during gestation, except in highly-selected 
patients [71]. 
Non ionizing procedures like ultrasound and MRI should be considered whenever possible 
[26,42,43,84-86]. Ideally, every radiology center should have their own data on fetal radiation exposure in 
order to determine the risks [28,61].  
[103,104] 
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LIMITATIONS 
During the construction of this systematic review the most hindering obstacle found was the 
conflicting data. An attempt to present the most information was made. Additionally, there were few 
original articles on fetal doses of exposure to radiation and absorbed values. More studies are needed in 
order to warrant the safety of diagnostic exams using radiation. 
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Minimal threshold doses vs Accepted 
cumulative radiation during pregnancy 
Minimal Threshold Dose (mGy) Accepted Cumulative Dose (mGy)
Table 1: Fetal Exposure, Fetal Equivalent and Effective Doses. 
 
 
 Fetal Exposure (mGy) 
Fetal 
Equivalent 
(mSv) 
Effective Dose (mSv) 
Article  
 
Exam 
McCollough, 
Schueler et al 
[29]
 
Wieseler, 
Bhargava 
et al [43] 
Toppenberg, 
Hill et al [9] 
Hurwitz, 
Yoshizumi 
et al [103] 
Helmrot, 
Petterson 
et al [104] 
Damilakis, 
Perisinakis 
et al [35] 
Parmaksiz, 
Atac et al 
[18]
 
Lockwood, 
Einstein et 
al [24] 
Goodman 
and 
Amurao [4] 
Parmaksiz, 
Atac et al  
[18]
 
Radiographic and Fluoroscopic examinations 
Cervical spine  
(AP, lat) < 0.001      0   
0.1 
(0.007-0.2) 
Extremities < 0.001  0.01        
Chest  
(PA, lat) 0.002  0.0007  0.001 
0.0013-
0.0138  0.06 0.02  
Chest (AP)     <0.001 0.0014-0.024 
1.4  
(0.001-8.7)   
1.4  
(0.1-4.3) 
Thoracic spine  
(AP, lat) 0.003          
Abdomen 
(AP): 
patient 
thickness 
21 
cm 
1  2.45  0.31-0.63 
0.0021-
0.036 
(0.0006-
0.107) 
3.5 -7.6  
(1.2-14)   
1.6-4.5  
(0.4-8.5) 
33 
cm 
3          
Lumbar spine  
(AP, lat) 1  3.59  0.91-1.75  
0.9-2.7  
(0.4-5.3) 2.1  
0.4-0.9  
(0.2-1.3) 
Pelvis   2.5  0.66-0.72  1.8  (0.7-2.9)  0.6 
1  
(0.4-1.5) 
Small bowel study 7       15   
Double contrast 
barium enema 
study 
7  39.86  7.8   8.7 8  
Mammography        0.6 0.4  
Ventilation-
perfusion scan   2.15     6.8   
Table 1: Fetal Exposure, Fetal Equivalent and Effective Doses are presented. (AP – anterior-posterior; lat – lateral; PA – posterior-anterior; CT – Computed 
Tomography) 
 
 
Computed Tomography 
Head CT 0  0.5     1.8   
Chest CT routine 0.2 0.02   0.21  0.04  (0.03-0.06) 7.8  
3.9  
(2.3-5.4) 
Chest CT 
pulmonary 
embolus 
0.2 0.02  0.24-0.66       
Lumbar spine   35        
CT angiography of 
coronary arteries 0.1       10   
Abdominal routine 4 1.3 26    28  (7.3-98) 7.6  
24.5  
(4.3-86) 
Abdominal/Pelvis 25 13       21  
CT angiography of 
aorta (chest 
through pelvis) 
34 13         
Abdomen/ pelvis, 
stone protocol 10 11 13.98 
Early 1st T: 
4-7.2 
End 1st T: 
8.5-11.7 
13.8-15.8   44.1   
 Table 2: Mean and Maximum of Fetal Exposure, Fetal Equivalent and Effective Doses. AP – 
anterior-posterior; lat – lateral; PA – posterior-anterior; CT – Computed Tomography. 
 
Table 2: Mean and Maximum of Fetal Exposure, Fetal Equivalent and Effective Doses. 
Table 3: Number of exams needed to reach the accepted cumulative dose of fetal exposure. 
Table 3: Number of radiographic, fluoroscopic and computed tomography exams needed to reach 50 
mGy of fetal exposure (the accepted cumulative dose). The mean and maximum exposure doses were 
used to calculate the number of exams needed. None of the exams presented reached the accepted level 
with one single exposure. AP – anterior-posterior; lat – lateral; PA – posterior-anterior; CT – Computed 
Tomography. 
 
 
Table 1 Protocol: Minimum and maximum threshold doses for deterministic effects on each 
gestational period. 
 
